Biofrontera Inc. has been notified by The Nasdaq Stock Market of its failure to meet the continued listing requirement under Nasdaq Listing Rule 5550(b)(1). As of May 21, 2025, the company's stockholders' equity was reported at $469,000, falling short of the minimum $2,500,000 requirement. Additionally, Biofrontera did not satisfy alternative criteria including a $35 million market value of listed securities or a net income of $500,000. The notice does not immediately affect trading of Biofrontera's securities. The company has 45 days to submit a compliance plan and, if accepted, could have up to 180 days to meet the requirements. If the plan is rejected, Biofrontera can appeal to a Nasdaq Hearings Panel.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。